Heart Failure – Boehringer Ingelheim 1378-0018

Profound Research and Michigan Healthcare Professionals are enrolling a heart Failure study that is assessing an investigational medication to see if it reduces the time to your next cardiovascular event.

To be eligible to participate, you must:

  • Be at least 18 years of age
  • Have chronic heart failure for at least 3 months with an ejection fraction < 40%
  • Be on an ACE inhibitor, an ARB, or an ARNi and a beta-blocker
    • ACE inhibitor: Lisinopril, Enalapril, Captopril, Benazepril, Ramipril, Quinapril
    • ARB: Azilsartan, Eprosartain, Telmisartan, Losartan, Candesartan, Irbesartan, Valsartan, Olmesartan
    • ARNi: Entresto
    • Beta-blockers: Nadolol, Pindolol, Sotalol, Acebutolol, Penbutolol, Propranolol, Timolol, Betaxolol, Bisoprolol, Metoprolol

Qualified participants will receive:

  • Study-related care and study medication at no cost
  • Financial compensation up to $2448 for time and travel expenses
View Study on ClinicalTrials.gov

Trial Interest Form

Locations

Michigan Healthcare Professionals TriAtria

32255 Northwestern Hwy
Suites 130 & 160
Farmington Hills, Michigan

Cardiology and Vascular Associates

42557 Woodward Ave
Suites 200 & 230
Bloomfield Hills, Michigan